Status:
TERMINATED
Metabolic Imaging Predict Histopathologic Response to Preop ChemoXRT for Locally Advanced Rectal CA
Lead Sponsor:
Stanford University
Collaborating Sponsors:
Stanford Cancer Council
Conditions:
Rectal Cancer
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
In this research study of metabolic imaging in locally advanced rectal cancer, we hope to learn whether new medical imaging technology can help predict the response of rectal cancer to preoperative ch...
Eligibility Criteria
Inclusion
- You must be diagnosed with locally advanced rectal cancer and have chosen treatment with preoperative chemoradiotherapy followed by surgery, which is a standard treatment approach for this disease.
Exclusion
- You are ineligible for this study if you are pregnant or under the age of 18 years old.
Key Trial Info
Start Date :
October 1 2003
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 1 2005
Estimated Enrollment :
15 Patients enrolled
Trial Details
Trial ID
NCT00394615
Start Date
October 1 2003
End Date
October 1 2005
Last Update
March 29 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Stanford University School of Medicine
Stanford, California, United States, 94305